SIMCERE PHARMA (02096) announced that Ms. Huang Huiling has resigned as a co-company secretary of the company, effective March 25, 2026. Ms. Mai Baowen has been appointed as a co-company secretary, effective from March 25, 2026. Mr. Wan Yushan will continue to serve as the other co-company secretary. The Stock Exchange has confirmed that Mr. Wan meets the requirements under Rule 3.28 of the Listing Rules and is qualified to act as the company's secretary.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments